When does Regeneron Pharmaceuticals, Inc. report earnings?
Regeneron Pharmaceuticals, Inc. reports earnings every quartal, last Regeneron Pharmaceuticals, Inc. earnings report date was 31/03/2021.
How much is Regeneron Pharmaceuticals, Inc. earnings per share?
Regeneron Pharmaceuticals, Inc. estimated earnings per share was 9.89 $ last time.
When is Regeneron Pharmaceuticals, Inc. next earnings report?
Next Regeneron Pharmaceuticals, Inc. earnings call will be in June 2024.
Regeneron Pharmaceuticals, Inc. earnings per share of the company - one of the indicators of the company's income from the size of its value. Earnings per share - calculated value: the total profit for the reporting period is divided by the number of existing shares. It is clear that Regeneron Pharmaceuticals, Inc. earnings per share is a financial characteristic for a certain period. Profit of Regeneron Pharmaceuticals, Inc. - the organization’s reported profit for the financial interval specified by law.
Show:
to
Regeneron Pharmaceuticals, Inc. earnings report
All Regeneron Pharmaceuticals, Inc. profits are a reference. It is not so important to private shareholders. A much more interesting indicator is earnings per share, which directly affects the amount of dividends per share. The date of the profit report Regeneron Pharmaceuticals, Inc. is tied to the legislation of the country of registration of the company. All dates of Regeneron Pharmaceuticals, Inc. profit reports are shown in our schedule and our table.
Regeneron Pharmaceuticals, Inc. quarterly earnings
Earnings per share Regeneron Pharmaceuticals, Inc. is calculated by dividing the company's profit by the number of its shares. Earnings per share Regeneron Pharmaceuticals, Inc. is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. Regeneron Pharmaceuticals, Inc. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit Regeneron Pharmaceuticals, Inc. is the most common type of financial report for financial analytics.
REGN earnings date
Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
31/03/2021
9.89 USD
-
31/12/2020
9.53 USD
+27.07% ↑
30/09/2020
8.36 USD
+25.34% ↑
30/06/2020
7.16 USD
+18.94% ↑
31/12/2019
7.5 USD
+23.6% ↑
30/09/2019
6.67 USD
+23.9% ↑
30/06/2019
6.02 USD
+15.2% ↑
31/03/2019
4.45 USD
+25.67% ↑
31/12/2018
6.84 USD
+23.67% ↑
30/09/2018
5.87 USD
+33.36% ↑
30/06/2018
5.45 USD
+48.26% ↑
31/03/2018
4.67 USD
+42.19% ↑
31/12/2017
5.23 USD
+49.53% ↑
30/09/2017
3.99 USD
+42.21% ↑
30/06/2017
4.17 USD
+19.56% ↑
31/03/2017
2.92 USD
+18.6% ↑
31/12/2016
3.04 USD
-10.934% ↓
30/09/2016
3.13 USD
-18.0598% ↓
30/06/2016
2.82 USD
-4.6082% ↓
31/03/2016
2.57 USD
-3.929% ↓
31/12/2015
2.83 USD
+19.27% ↑
30/09/2015
3.47 USD
+24.15% ↑
30/06/2015
2.89 USD
+20.76% ↑
31/03/2015
2.88 USD
+21.93% ↑
31/12/2014
2.79 USD
+186.59% ↑
30/09/2014
2.52 USD
+184.61% ↑
30/06/2014
2.47 USD
+161.62% ↑
31/03/2014
2.26 USD
+124.92% ↑
31/12/2013
0.86 USD
-11.887% ↓
30/09/2013
1.25 USD
-4.49% ↓
30/06/2013
0.79 USD
+229.25% ↑
31/03/2013
0.9 USD
-525.274% ↓
31/12/2012
1.22 USD
-283.005% ↓
30/09/2012
1.72 USD
-224.67% ↓
30/06/2012
0.7 USD
-165.249% ↓
31/03/2012
0.16 USD
-35.754% ↓
31/12/2011
-0.54 USD
-46.397% ↓
30/09/2011
-0.68 USD
-55.541% ↓
30/06/2011
-0.69 USD
-8.163% ↓
31/03/2011
-0.49 USD
-27.125% ↓
31/12/2010
-0.17 USD
-4.041% ↓
30/09/2010
-0.41 USD
-40.356% ↓
30/06/2010
-0.31 USD
-24.533% ↓
31/03/2010
-0.38 USD
-37.15% ↓
31/12/2009
-0.46 USD
-10.266% ↓
30/09/2009
-0.01 USD
-36.693% ↓
30/06/2009
-0.19 USD
-7.213% ↓
31/03/2009
-0.22 USD
-4.792% ↓
31/12/2008
-0.4 USD
-36.514% ↓
30/09/2008
-0.27 USD
-5.0614% ↓
30/06/2008
-0.23 USD
-28.793% ↓
31/03/2008
-0.15 USD
-34.619% ↓
31/12/2007
-0.19 USD
-6.74% ↓
30/09/2007
-0.54 USD
-46.365% ↓
30/06/2007
-0.41 USD
-24.189% ↓
31/03/2007
-0.46 USD
-19.13% ↓
31/12/2006
-0.51 USD
-22.237% ↓
30/09/2006
-0.48 USD
-5.28% ↓
30/06/2006
-0.41 USD
-8.85% ↓
31/03/2006
-0.36 USD
-55% ↓
31/12/2005
-0.53 USD
-44.648% ↓
30/09/2005
-0.52 USD
-33.258% ↓
30/06/2005
-0.38 USD
-41.101% ↓
31/03/2005
-0.07 USD
-36.307% ↓
31/12/2004
0.05 USD
-31.698% ↓
30/09/2004
-0.2 USD
-24.571% ↓
30/06/2004
-0.26 USD
-45.346% ↓
31/03/2004
1.06 USD
-48.718% ↓
31/12/2003
-0.35 USD
-37.463% ↓
30/09/2003
-0.52 USD
-32.692% ↓
30/06/2003
-0.58 USD
-12.941% ↓
31/03/2003
-0.68 USD
-26.331% ↓
31/12/2002
-0.81 USD
-
30/09/2002
-0.75 USD
-
30/06/2002
-0.69 USD
-
31/03/2002
-0.58 USD
-
Regeneron Pharmaceuticals, Inc. quarterly earnings per share are the estimated profitability of the company. They have intermediate significance among analysts. But annual earnings per share are of primary importance. Last quarterly profit Regeneron Pharmaceuticals, Inc. today is the officially declared profit for the last reference quarter. Change in profit Regeneron Pharmaceuticals, Inc. for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. The change in quarterly profit of Regeneron Pharmaceuticals, Inc. is a less significant value relative to the change in annual profit of Regeneron Pharmaceuticals, Inc..
The change in profit is shown as a percentage. The profit history of Regeneron Pharmaceuticals, Inc. for previous years is given in our table “Quarterly profit”. Regeneron Pharmaceuticals, Inc. quarterly earnings history is available online for each year and quarter over the past ten years. The database of profit for the past year and other periods of Regeneron Pharmaceuticals, Inc. is compiled from public sources.
Regeneron Pharmaceuticals, Inc. stocks data
REGN stock price
Regeneron Pharmaceuticals, Inc. stock price today, REGN stock quote.
